Systemic muscular weakness after botulinum toxin A administration: a review of the literature

Author(s):  
Jennifer A. Locke ◽  
Helia Nabavian ◽  
Sarah Neu ◽  
Sender Herschorn ◽  
Lesley K. Carr
2019 ◽  
Vol 18 (1) ◽  
pp. 97-103
Author(s):  
Jiaojiao Zhong ◽  
Yu Lan ◽  
Shuying Fu ◽  
Jing Zhang ◽  
Sha Lu ◽  
...  

Chronic skin ulcer (CSU) often combines with a variety of refractory factors that respond poorly to routine treatments. Botulinum toxin A (BTX-A) can be injected subcutaneously to improve the local blood supply, to reduce pain, and to promote wound healing. At present, few reports have mentioned BTX-A injection for chronic skin ulcer treatment. We observed the effect of four cases that used BTX-A to treat CSU and provided a brief review of the literature. Four cases of CSUs with 4 different causes were treated with BTX-A injection (4 U/cm2). The specific operation is as follows: local, multipoint, cyclic, equidistant, and subcutaneous injections with a depth of 6 to 8 mm. The ulcer area was significantly reduced. Subsequently, the ulcer healed within 20 to 48 days. Botulinum toxin A is recommended as an important treatment for chronic skin ulcer that can improve healing of skin ulcers with various etiologies.


2007 ◽  
Vol 177 (4S) ◽  
pp. 393-393
Author(s):  
Yao-Chi Chuang ◽  
Yao-Chi Chuang ◽  
Dae Kyung Kim ◽  
Po-Hui Chiang ◽  
Michael B. Chancellor

2005 ◽  
Vol 173 (4S) ◽  
pp. 305-305
Author(s):  
Brigitte Schurch ◽  
Marianne de Seze ◽  
Pierre Denys ◽  
Emmanuel Chartier-Kastler ◽  
Francois Haab ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document